title: Impact of Cosmetic Camouflage on the Quality of Life of Children With Skin Disease and Their Families.
abstract: OBJECTIVE
  Cosmetic camouflage is known to improve quality of life in adults. Few data are available regarding cosmetic camouflage in children, and thus it is not often selected as a mode of treatment. We sought to determine whether cosmetic camouflage leads to improved quality of life of pediatric patients with visible dermatoses and their parent or primary caregiver.
  
  
  METHODS
  Patients aged 5 to 17 years with visible skin disease and their parent were assessed with the Children's Dermatology Life Quality Index (CDLQI) and the Family Dermatology Life Quality Index (FDLQI) before and after consultation regarding cosmetic camouflage.
  
  
  RESULTS
  Twenty-two children with skin conditions were included in the study. The mean CDLQI decreased from 6.82 (SD = 1.28) to 3.05 (SD = 0.65; P = .0014), while the mean FDLQI decreased from 7.68 (SD = 1.15) to 4.68 (SD = 0.92; P = .0012).
  
  
  CONCLUSIONS
  Our study highlighted improvement in quality of life in patients with skin disorders who were managed with cosmetic camouflage.
authors.affiliation: Women's College Hospital, Toronto, Ontario Jennifer.kwinter@mail.utoronto.ca.
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Salsberg
authors.affiliation: The Hospital for Sick Children, Toronto, Ontario.
authors.forename: Miriam
authors.initials: M
authors.lastname: Weinstein
authors.affiliation: Sunnybrook Health Sciences Centre, Toronto, Ontario.
authors.forename: Neil
authors.initials: N
authors.lastname: Shear
authors.affiliation: The Hospital for Sick Children, Toronto, Ontario.
authors.forename: Michelle
authors.initials: M
authors.lastname: Lee
authors.affiliation: The Hospital for Sick Children, Toronto, Ontario.
authors.forename: Elena
authors.initials: E
authors.lastname: Pope
mesh_terms: D000293:Adolescent; D019080:Cafe-au-Lait Spots / Q000523:psychology / Q000534:rehabilitation; D002648:Child; D002921:Cicatrix / Q000523:psychology / Q000534:rehabilitation; D003358:Cosmetics / Q000627:therapeutic use*; D005121:Extremities; D005145:Face; D005260:Female; D006801:Humans; D008297:Male; D009506:Nevus / Q000151:congenital / Q000523:psychology / Q000534:rehabilitation; D010290:Parents / Q000523:psychology*; D017060:Patient Satisfaction; D011788:Quality of Life; D012594:Scleroderma, Localized / Q000523:psychology / Q000534:rehabilitation; D012871:Skin Diseases / Q000523:psychology / Q000534:rehabilitation*; D017445:Skin Diseases, Vascular / Q000523:psychology / Q000534:rehabilitation; D012878:Skin Neoplasms / Q000523:psychology / Q000534:rehabilitation; D054079:Vascular Malformations / Q000523:psychology / Q000534:rehabilitation; D014820:Vitiligo / Q000523:psychology / Q000534:rehabilitation
chemical_list: D003358:Cosmetics
keywords: dermatology; inflammatory dermatoses; pediatric; pigmentary disorder